Aveanna Healthcare has strung together four straight earnings beats with a 118% average positive surprise and trades at a forward price-to-earnings multiple of 9.4 times — but a debt-to-equity ratio of 6.2 and free cash flow converting at only 32% of net income are meaningful structural risks that cap near-term position size.
Thesis pillars
- Strong Earnings Beat Streak↑Improving
- Attractive Growth Adjusted Valuation↓Deteriorating
- High Leverage Financial Vulnerability→Stable
- +2 more pillars — see the Why tab for full reasoning
Aveanna Healthcare Holdings Inc (AVAH) Stock Analysis
Healthcare · Medical Care Facilities
Sell if holding. Analyst target reached at $12.32 — A.R:R is negative (-1.7) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Customer: Medicare, Medicaid and private health insurance payers.
Aveanna Healthcare is the largest provider of private duty nursing (PDN) services in the United States, operating through three segments: Private Duty Services, Home Health & Hospice, and Medical Solutions. The company has completed and integrated eighteen acquisitions since... Read more
Sell if holding. Analyst target reached at $12.32 — A.R:R is negative (-1.7) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Customer: Medicare, Medicaid and private health insurance payers. Chart setup: No clear chart pattern; technical signals are mixed. Score 6.2/10, moderate confidence.
Passes 6/8 gates (positive momentum, no SEC red flags, news events none recent, earnings proximity no date, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio and clean insider activity. Suitability: aggressive.
Recent developments
updated 2026-08-15Recent Developments — Aveanna Healthcare Holdings Inc
Latest news
- NEWS Is Aveanna Healthcare (AVAH) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance — Yahoo Finance positive
- NEWS Aveanna (AVAH) Stock Analysis: +0.66% Gain — What to Watch 2026-05-20 - Bullish Percent Index - Newser — Newser positive
- NEWS Aveanna Healthcare: Q1 Results Confirm My Reasons For Optimism (NASDAQ:AVAH) - Seeking Alpha — Seeking Alpha positive
- NEWS Janus Henderson Group PLC Lowers Stock Position in Aveanna Healthcare Holdings Inc. $AVAH - MarketBeat — MarketBeat neutral
- NEWS AVAH vs. CHE: Which Stock Should Value Investors Buy Now? - Yahoo Finance — Yahoo Finance neutral
Generated 2026-08-15T13:12:17Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHCustomerMedicare, Medicaid and private health insurance payers10-K Item 1A: 'Third-party payers including Medicare, Medicaid and private health insurance payers provide substantially all funding for our home health and hospice services'
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker·1 ceiling hit
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Analyst target reached at $12.32 — A.R:R is negative (-1.7) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Customer: Medicare, Medicaid and private health insurance payers. Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $11.46. Score 6.2/10, moderate confidence.
Take-profit target: $14.17 (-25.5% upside). Prior stop was $11.46. Stop-loss: $11.46.
Concentration risk — Customer: Medicare, Medicaid and private health insurance payers; Analyst target reached - limited upside remaining; Near 52-week high (1.6% away).
Aveanna Healthcare Holdings Inc trades at a P/E of 9.8 (forward 14.2). TrendMatrix value score: 7.3/10. Verdict: Sell.
17 analysts cover AVAH with a consensus score of 4.1/5. Average price target: $11.
What does Aveanna Healthcare Holdings Inc do?Aveanna Healthcare is the largest provider of private duty nursing (PDN) services in the United States, operating...
Aveanna Healthcare is the largest provider of private duty nursing (PDN) services in the United States, operating through three segments: Private Duty Services, Home Health & Hospice, and Medical Solutions. The company has completed and integrated eighteen acquisitions since 2017 to build a national home-care platform, with Medicare, Medicaid, and private insurers funding substantially all of its home health and hospice revenue.